Literature DB >> 3791150

Lymphocyte predominance Hodgkin's disease. A clinicopathologic reassessment.

M A Trudel, J G Krikorian, R S Neiman.   

Abstract

A clinicopathologic analysis of 35 cases of lymphocyte predominance Hodgkin's disease (LPHD) was performed, and the relationship between various histologic features and stage at presentation was examined. The series comprised 31 male and 4 female patients with a median age of 32 years. Twenty patients had Ann Arbor Stage I disease; 5, Stage II; 8, Stage III; and 2, Stage IV. Eight cases showed a multifocal epithelioid histiocytic reaction; six of these had advanced-stage (III or IV) disease (P = 0.003). Five cases contained relatively frequent atypical mononuclear cells; four of these were Stage III or IV (P = 0.017). A purely diffuse growth pattern was also associated with high stage (P = 0.031). Presence of nodularity correlated with low stage (P = 0.031). During follow-up (median, 4 years; range, 2.5 months-18 years) there was a high incidence of second neoplasms (2 large cell lymphomas, 3 non-hematologic malignancies). LPHD manifests greater diversity of stage at presentation than originally thought. A high content of epithelioid histiocytes, relatively frequent atypical mononuclear cells, and diffuse histology appear to define subsets associated with advanced-stage disease. The correlation of nodular growth pattern with low-stage disease is consistent with the distinctive behavior and derivation of nodular LPHD.

Entities:  

Mesh:

Year:  1987        PMID: 3791150     DOI: 10.1002/1097-0142(19870101)59:1<99::aid-cncr2820590122>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Nodular lymphocyte-predominant Hodgkin's lymphoma.

Authors:  Lucia Nogovà; Volker Diehl; Andreas Engert
Journal:  Curr Hematol Malig Rep       Date:  2006-03       Impact factor: 3.952

2.  [IF-RT alone remains gold standard for stage IA nodular lymphocyte-predominant Hodgkin lymphoma].

Authors:  Karoline Pilz; Christina Jentsch; Mechthild Krause
Journal:  Strahlenther Onkol       Date:  2016-06       Impact factor: 3.621

Review 3.  Clinical aspects of Hodgkin's disease.

Authors:  G M Mead; J M Whitehouse
Journal:  BMJ       Date:  1988-12-17

4.  A 26-year-old man with Hodgkin's disease and rapidly progressive pancytopenia.

Authors:  J C Kluin-Nelemans; P M Kluin; R Bieger
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

5.  Nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Michael Fuchs; Dennis A Eichenauer; Lucia Nogová; Volker Diehl; Andreas Engert
Journal:  Curr Hematol Malig Rep       Date:  2008-07       Impact factor: 3.952

6.  Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia.

Authors:  G Li; M L Hansmann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.